Acute Kidney Injury in Children Operated for Congenital Heart Disease

NCT ID: NCT01316497

Last Updated: 2012-09-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-07-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to investigate if repeated inflation of a blood pressure cuff applied around one leg causing mild ischemia ("remote ischemic preconditioning") could protect children operated for congenital heart disease from developing acute kidney injury.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Remote ischemic preconditioning (RIPC) refers to an intervention of remote, brief ischemia which confers systemic protection against consequences of reperfusion injury in distant organs. RIPC has been shown to protect various organs during major surgeries. Our hypothesis was that RIPC could protect kidney function in children operated for complex congenital heart disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Kidney Injury

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Acute kidney injury Ischemic preconditioning Congenital heart defects Cardiac surgical procedures Infant Child

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Remote ischemic preconditioning (RIPC)

See intervention description

Group Type EXPERIMENTAL

Remote ischemic preconditioning (RIPC)

Intervention Type PROCEDURE

RIPC was performed by applying a blood pressure cuff around the child's leg. The cuff was inflated to 40 mmHg above the systolic pressure in 4 cycles of 5 minutes. Every cycle of ischemia was followed by 5 minutes of reperfusion. The first RIPC cycle started after anesthesia induction when invasive arterial blood pressure was monitored. Appropriate cuff size was used choosing between four sizes. For reproducibility RIPC was performed on the right leg with only a few exceptions, when the leg was used for invasive catheters.

Control

Group Type PLACEBO_COMPARATOR

Control

Intervention Type PROCEDURE

The cuff was applied on the leg without inflation in the control group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Remote ischemic preconditioning (RIPC)

RIPC was performed by applying a blood pressure cuff around the child's leg. The cuff was inflated to 40 mmHg above the systolic pressure in 4 cycles of 5 minutes. Every cycle of ischemia was followed by 5 minutes of reperfusion. The first RIPC cycle started after anesthesia induction when invasive arterial blood pressure was monitored. Appropriate cuff size was used choosing between four sizes. For reproducibility RIPC was performed on the right leg with only a few exceptions, when the leg was used for invasive catheters.

Intervention Type PROCEDURE

Control

The cuff was applied on the leg without inflation in the control group.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children admitted for surgery for congenital heart disease

Exclusion Criteria

* heart surgeries of low complexity such as closure of septal defects, aortico-pulmonary windows, establishment of glenn shunts, subaortic membrane resection, redirection of anomalous pulmonary veins, valvotomies, repair of pulmonary artery stenosis and surgeries without the use of extracorporeal circulation
Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aase and Ejnar Danielsens Foundation

OTHER

Sponsor Role collaborator

The Augustinus Foundation, Denmark.

OTHER

Sponsor Role collaborator

Direktør Kurt Bønnelycke and Hustru fru Grethe Bønnelyckes Foundation

UNKNOWN

Sponsor Role collaborator

Helen and Ejnar Bjørnows Foundation

UNKNOWN

Sponsor Role collaborator

Raimond and Dagmar Ringgård-Bohn's Foundation

OTHER

Sponsor Role collaborator

Grosserer L.F. Foghts Foundation

UNKNOWN

Sponsor Role collaborator

Snedkermester Sophus Jacobsen and hustru Astrid Jacobsens Foundation

OTHER

Sponsor Role collaborator

The Dagmar Marshall Foundation

OTHER

Sponsor Role collaborator

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kirsten MR Pedersen, MD

Role: STUDY_DIRECTOR

Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Skejby

Vibeke E Hjortdal, MD PhD DMSc

Role: PRINCIPAL_INVESTIGATOR

Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Skejby

Hanne B Ravn, MD PhD

Role: STUDY_CHAIR

Department of Anesthesia and Intensive Care, Aarhus University Hospital, Skejby

Johan V Povlsen, MD

Role: STUDY_CHAIR

Department of Renal Medicine C, Aarhus University Hospital, Skejby

Michael R Schmidt, MD PhD

Role: STUDY_CHAIR

Aarhus University Hospital

Erland Erlandsen, MSc

Role: STUDY_CHAIR

Department of Clinical Biochemistry, Viborg Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Skejby

Aarhus, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

References

Explore related publications, articles, or registry entries linked to this study.

Pedersen KR, Povlsen JV, Christensen S, Pedersen J, Hjortholm K, Larsen SH, Hjortdal VE. Risk factors for acute renal failure requiring dialysis after surgery for congenital heart disease in children. Acta Anaesthesiol Scand. 2007 Nov;51(10):1344-9. doi: 10.1111/j.1399-6576.2007.01379.x.

Reference Type BACKGROUND
PMID: 17944638 (View on PubMed)

Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol. 2006 Jun 6;47(11):2277-82. doi: 10.1016/j.jacc.2006.01.066. Epub 2006 May 15.

Reference Type BACKGROUND
PMID: 16750696 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20080052

Identifier Type: -

Identifier Source: org_study_id